The 36th annual International Congress of German Ophthalmic Surgery (DOC) comes to Nuremberg

News
Article

Sustainability, artificial intelligence and economic considerations are hot topics at this year’s meeting

A cityscape of older buildings in historic Nuremberg, Germany. Image credit: ©Travel Faery – stock.adobe.com

Simultaneous translation will be available during all three days of the meeting. Image credit: ©Travel Faery – stock.adobe.com

From 20 to 22 June, the 36th International Congress of German Ophthalmic Surgery (DOC) will convene in Nuremberg, at the Nuremberg Convention Center, NCC East. Attendees can partake in a series of wetlabs, educational symposia and discussion seminars, as well as social events. Industry exhibitors will be on-site to educate practitioners about recent pharmaceutical research. During all three days of the meeting, simultaneous translation will be available in Tokio Hall at the Convention Center.

In a welcome letter, Armin Scharrer, MD, President of the DOC, addressed his colleagues1 and provided a brief preview of the programme. He said that the goal of the main symposia is to elevate the “gold standards” of eye surgery, and provide comprehensive, practice-oriented training for those in the audience.

Furthermore, Dr Scharrer spoke to the breadth and depth of topics that will be addressed in the surgical courses. “In addition to master class courses, which provide an excellent overview in a condensed form of a sub-area of ​​ophthalmology/eye surgery, the surgery courses are also continuously being expanded,” he wrote. In surgery courses, participants will undergo a step-by-step walkthrough of each surgical procedure, supplemented by best practices for postoperative care.

Video live surgery, presented this year in conjunction with the Singapore National Eye Centre, will be a significant component of the congress, Dr Scharrer wrote. The videos will showcase “modern surgical techniques in difficult initial situations,” he said.1 In other sessions, speakers will discuss and debate divisive topics in ophthalmic surgery, headed by symposium chairs. “The task of the chair of a meeting is to actively shape the controversial discussion,” Dr Scharrer said. “The subjective, personal opinion of the chair is also of interest to the audience.”

He shared a list of topics that are new for 2024, which include the following: "Sustainability in ophthalmology and eye surgery,” “artificial intelligence [AI] in ophthalmology” and the professional policy session, "Do we need more or less economy in the healthcare system in Germany?" The congress will feature several different educational opportunities in the realm of practice management. Dr Scharrer noted that the meeting is not exclusive to those with medical degrees, but also offers a comprehensive programme for ophthalmological assistants in clinics and practices.

Information about the meeting, the participant portal, digital access and a help desk can be found at the DOC website: https://www.doc-nuernberg.de/index-e.php

Reference

  1. Scharrer, A. Greetings from Dr Armin Scharrer. International Congress of German Ophthalmic Surgery. Accessed 18 June, 2024. https://www.doc-nuernberg.de/grusswort-scharrer.php
Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.